Use of rasagiline for the treatment of olfactory dysfunction
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsGeraldine Petit, Patrik Brundin
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of treating olfactory dysfunction by periodically administering a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to a subject.
Claims13
A method of treating a symptom of olfactory dysfunction in a subject afflicted by olfactory dysfunction, the method comprising:
- a. identifying the subject as afflicted by olfactory dysfunction, and
- b. periodically administering to the subject so identified an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof, effective to treat the subject,
- wherein the subject is a non-Parkinson's disease subject.
A method of reducing the rate of progression of olfactory dysfunction in a non-Parkinson's disease subject afflicted by olfactory dysfunction, the method comprising periodically administering to the subject an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof effective to reduce the rate of progression of olfactory dysfunction in the non-Parkinson's disease subject.
A method of inhibiting loss of olfactory function in a non-Parkinson's disease subject, the method comprising periodically administering to the subject an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof effective to inhibit loss of olfactory function in the non-Parkinson's disease subject.
Dependencies are inferred from the claim text.